Healthcare & Life Sciences
Iambic Therapeutics
United Statesiambic.ai
Iambic Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2020
Founded
3
Investors
About Iambic Therapeutics
Based in the United States, Iambic Therapeutics is a startup founded in 2020. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Iambic Therapeutics uses AI-driven technologies combined with high-throughput experimentation to discover and develop optimized drug candidates, focusing on transforming undruggable targets and advancing first-in-class therapies for cancer.
Explore Iambic Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.